These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Safety of an Oncolytic Myxoma Virus in Dogs with Soft Tissue Sarcoma. MacNeill AL; Weishaar KM; Séguin B; Powers BE Viruses; 2018 Jul; 10(8):. PubMed ID: 30060548 [TBL] [Abstract][Full Text] [Related]
44. Seneca Valley Virus 3Cpro Substrate Optimization Yields Efficient Substrates for Use in Peptide-Prodrug Therapy. Miles LA; Brennen WN; Rudin CM; Poirier JT PLoS One; 2015; 10(6):e0129103. PubMed ID: 26069962 [TBL] [Abstract][Full Text] [Related]
45. Senecavirus A. Segalés J; Barcellos D; Alfieri A; Burrough E; Marthaler D Vet Pathol; 2017 Jan; 54(1):11-21. PubMed ID: 27371541 [TBL] [Abstract][Full Text] [Related]
46. Fighting Cancer with Viruses: Oncolytic Virus Therapy in China. Wei D; Xu J; Liu XY; Chen ZN; Bian H Hum Gene Ther; 2018 Feb; 29(2):151-159. PubMed ID: 29284308 [TBL] [Abstract][Full Text] [Related]
47. Treatment of invasive retinoblastoma in a murine model using an oncolytic picornavirus. Wadhwa L; Hurwitz MY; Chévez-Barrios P; Hurwitz RL Cancer Res; 2007 Nov; 67(22):10653-6. PubMed ID: 18006805 [TBL] [Abstract][Full Text] [Related]
48. Current status of clinical trials assessing oncolytic virus therapy for urological cancers. Taguchi S; Fukuhara H; Homma Y; Todo T Int J Urol; 2017 May; 24(5):342-351. PubMed ID: 28326624 [TBL] [Abstract][Full Text] [Related]
49. United virus: the oncolytic tag-team against cancer! Le Boeuf F; Bell JC Cytokine Growth Factor Rev; 2010; 21(2-3):205-11. PubMed ID: 20227326 [TBL] [Abstract][Full Text] [Related]
50. Virus, Oncolytic Virus and Human Prostate Cancer. Liu GB; Zhao L; Zhang L; Zhao KN Curr Cancer Drug Targets; 2017; 17(6):522-533. PubMed ID: 27993115 [TBL] [Abstract][Full Text] [Related]
51. Seneca Valley Virus 3C Xue Q; Liu H; Zhu Z; Xue Z; Liu X; Zheng H Pathogens; 2020 Jun; 9(6):. PubMed ID: 32512928 [TBL] [Abstract][Full Text] [Related]
55. Seneca Valley virus RNA detection in pig feed and feed ingredients in Brazil. Leme RA; Miyabe FM; Dall Agnol AM; Alfieri AF; Alfieri AA Transbound Emerg Dis; 2019 Jul; 66(4):1449-1453. PubMed ID: 31038274 [TBL] [Abstract][Full Text] [Related]
56. The use of the NIS reporter gene for optimizing oncolytic virotherapy. Miller A; Russell SJ Expert Opin Biol Ther; 2016; 16(1):15-32. PubMed ID: 26457362 [TBL] [Abstract][Full Text] [Related]
57. Questing for an optimal, universal viral agent for oncolytic virotherapy. Paiva LR; Martins ML; Ferreira SC Phys Rev E Stat Nonlin Soft Matter Phys; 2011 Oct; 84(4 Pt 1):041918. PubMed ID: 22181186 [TBL] [Abstract][Full Text] [Related]
58. Crystallization and preliminary X-ray diffraction studies of Seneca Valley virus-001, a new member of the Picornaviridae family. Venkataraman S; Reddy SP; Loo J; Idamakanti N; Hallenbeck PL; Reddy VS Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Apr; 64(Pt 4):293-6. PubMed ID: 18391430 [TBL] [Abstract][Full Text] [Related]
59. Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses. Saito K; Shirasawa H; Isegawa N; Shiiba M; Uzawa K; Tanzawa H Oral Oncol; 2009 Dec; 45(12):1021-7. PubMed ID: 19833547 [TBL] [Abstract][Full Text] [Related]
60. Novel oncolytic viruses: riding high on the next wave? Stanford MM; Bell JC; Vähä-Koskela MJ Cytokine Growth Factor Rev; 2010; 21(2-3):177-83. PubMed ID: 20219409 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]